Commentary on "A new cancer diagnostic system based on a CDK profiling technology" [Biochim. Biophys. Acta Molecular Basis of Disease 1741 (2005) 226-233].
Draetta
Giulio F
GF
Cancer Research, Merck Research Laboratories, Basic Research, 33 Avenue Louis Pasteur, Boston, MA 02115, USA. giulio_draetta@merck.com
D018844:Cyclin-Dependent Kinases / Q000378:metabolism*; D006801:Humans; D025202:Molecular Diagnostic Techniques / Q000379:methods*; D009369:Neoplasms / Q000175:diagnosis*; D015854:Up-Regulation
D018844:Cyclin-Dependent Kinases